Medicaid GLP-1 coverage — 12 month update

PedsEndoPhilly said:

TrialNerd_Beth said: ...compounded vs brand cost and coverage...

Financial impact of cost and coverage weight loss beyond medication cost:

• Groceries: SAVED $222/month (eating less)
• Restaurants: SAVED $152/month (fewer meals out)
• Alcohol: SAVED $102/month (stopped drinking)
• Life insurance: Premium REDUCED by $32/month (lower BMI)
• Copays: SAVED $52/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

fiona_VT said:

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives: Prior authorization appeal…

Bookmarking. The distinction being drawn above is the one nobody else makes. Adding it to my notes with a link back to this thread.

PedsEndoPhilly said:

TrialNerd_Beth said: ...compounded vs brand cost and coverage...

My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.

sarah_TO said:

Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

sarah_TO said:

...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

Moderator note: a couple of off-topic posts removed. Carry on.